GSK Exercises Option to License Chemo...

GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,...

There are 1 comment on the Sys-Con Media story from Jan 5, 2012, titled GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,.... In it, Sys-Con Media reports that:

"This announcement is a key milestone for ChemoCentryx that further validates our ability to advance new medicines from drug discovery through clinical development," said , Ph.D., President and Chief Executive Officer of ChemoCentryx.A "Furthermore, the exercise fee associated with this agreement provides additional financial flexibility to our ... (more)

Join the discussion below, or Read more at Sys-Con Media.

Robson

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Arthritis Discussions

Title Updated Last By Comments
News Many advancements made with knee replacements (Feb '14) 12 hr Stan Rusiecki 4
News How to File A Complaint About DIRECTV (Jul '08) May 25 Jsoudercont 233
News Livingston Teen Living with Arthritis Helps to ... May 13 aspirub 1
News Treatment Tips (Jan '13) Apr 30 Angela K 5
News Patients grapple with high cost of arthritis me... Apr '15 bethwalker85 1
News Causes of joint pain (Oct '08) Apr '15 docv2011 12
News Ask Dr. Gott: Behcet's uncommon, troublesome (Mar '10) Apr '15 Behcets Awareness... 3
More from around the web